Developer docs
API playgroundTry for free, no card

Search company profiles

Maximon

Full company profile

uuid00022da

Namestring
Maximon
Legal namestring
Maximon AG
Websiteurl
maximon.com
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersZug, Switzerland
HQ citystring
Zug
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
longevity company building, venture building services, healthy aging solutions, longevity investment fund, biotech venture incubation
Industry2 codes
PRIMARYHSADAGAK
Healthy Aging & Longevity Lifestyle Coaching
SECONDARYCRADAGAM
Healthy Aging & Cognitive Support Supplements
NAICS code2 codes
  • Corporate, Subsidiary, and Regional Managing Offices551114
  • Continuing Care Retirement Communities623311
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Longevity Company Building and Venture Investment
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Company Builder Equity Stakes
TypeSubscription Recurring
Description

Maximon builds and operationalizes longevity companies from scratch, taking equity stakes in portfolio companies. As companies become operational and profitable (e.g., Avea Life reaching profitability), Maximon benefits through equity appreciation and potential exits.

maximon.com
2Longevity Co-Investment Fund Management
TypeSubscription Recurring
Description

Maximon manages the Longevity Co-Investment Fund (LCIF) targeting CHF 100 million with minimum tickets of CHF 500,000 for qualified investors. Additional investment vehicle launched January 2024 for qualified investors. Revenue derived from management fees and carried interest.

maximon.com
3Actively Managed Certificate (AMC)
TypeSubscription Recurring
Description

Partnership with Marcuard Heritage and GenTwo to offer an AMC structure allowing professional investors access to Maximon's longevity portfolio starting at CHF 10,000, democratizing longevity investments.

maximon.com
4Longevity Clinic Services
TypeSubscription Recurring
Description

Portfolio company AYUN operates a longevity clinic in Zurich offering subscription-based health services including comprehensive check-ups, biomarker analysis, and personalized longevity programs.

maximon.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Pricing details3 tiers
1Longevity Co-Investment Fund (LCIF) for qualified institutional investors
ModelSubscriptionBilling cadenceAnnual
Notes

Minimum ticket of CHF 500,000

maximon.com
2Actively Managed Certificate (AMC) for professional investors
ModelSubscriptionBilling cadenceAnnual
Notes

Minimum investment starting at CHF 10,000, significantly lower barrier to entry than LCIF

maximon.com
3AYUN Longevity Clinic subscription services
ModelSubscriptionBilling cadenceMonthly
Notes

Service pricing revealed for early bookers; subscription model for ongoing longevity services

maximon.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1AVEA
Description

Evidence-based longevity supplements company

maximon.com
+4 more records
Core offering1 text field

Maximon is a longevity company builder that identifies promising business opportunities in the healthy aging and rejuvenation sector and builds companies from scratch, providing funding, operational infrastructure, HR support, and a curated ecosystem. The company also manages the Longevity Co-Investment Fund (LCIF) with a CHF 100 million target volume for institutional investors, and operates portfolio companies spanning supplements, longevity clinics, women's health, and senior living.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Avea Life growing at 300-400% annually and already profitable within 2.5 years of market entry
+2 more records
Product overview1 text field

Maximon is a longevity company builder that identifies business opportunities in the longevity field and builds companies from scratch. The company operates as a platform with multiple portfolio ventures at various stages: operational companies (Evidence-Based Longevity Supplements, Data-Driven Health Analytics, Avea Life), launching ventures (LIV Lounge, Senior Co-Living, AYUN clinic), and stealth projects (Maximon X). Key offerings include AYUN (longevity clinic), Avea Life (supplements), Frieda Health (women's health platform), alongside investment vehicles like the Longevity Co-Investment Fund and the annual Longevity Investors Conference. Maximon provides proven structures, financing, and an ecosystem for entrepreneurs building longevity ventures.

Product and service7 records
1Evidence-Based Longevity Supplements (AVEA)
CategoryLongevity Supplements
Description

A portfolio venture (AVEA) developing and commercializing evidence-based dietary supplements targeted at extending healthspan and promoting healthy aging. Includes Collagen Activator formula and other longevity supplements for health-conscious consumers and corporate partners like SailGP German Team.

2AYUN Longevity Clinic
CategoryLongevity Health Services
Description

A portfolio venture (AYUN) operating a longevity clinic in Zurich offering personalized health assessments, preventive medicine services, biomarker analysis, and personalized longevity programs on a subscription basis. Particularly popular among financial sector professionals seeking health optimization.

3Frieda Health Digital Platform
CategoryWomen's Health Digital Platform
Description

A portfolio venture (Frieda Health) providing a digital health platform focused on women's health, particularly for women aged 45+ during menopause. Raised EUR 2.5 million in pre-seed funding from Maximon.

4Longevity Co-Investment Fund (LCIF)
CategoryInvestment Fund
Description

A co-investment fund with target volume of CHF 100 million for longevity ventures. Minimum ticket of CHF 500,000 for direct investment, with an actively managed certificate (AMC) option starting at CHF 10,000 for professional investors via the Marcuard Heritage and GenTwo partnership.

5Data-Driven Health Analytics
CategoryHealth Data Analytics
Description

A portfolio venture (operational status) providing data analytics solutions for health insights and longevity optimization.

6Senior Co-Living
CategorySenior Housing Services
Description

A portfolio venture (launching status) focused on co-living solutions for active and healthy seniors, addressing housing and community needs for the longevity society.

7LIV Lounge
CategoryLongevity Services
Description

A portfolio venture (launching status) focused on longevity services within the Maximon ecosystem.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Health2Wealth Association
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-07-02
Description

AYUN partnered with Health2Wealth Association for a longevity networking event, expanding reach to health and wellness professionals and enthusiasts.

maximon.com
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-06-17
Description

AVEA became Official Supplier of the SailGP German Team, demonstrating B2B enterprise adoption of longevity supplements for athletic performance optimization.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-05-29
Description

Avea partnered with Eat by Alex to infuse Avea's Collagen Activator formula into a special version of their clean plant protein powder, expanding product distribution.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-13
Description

Longevity Investors partnered with XPRIZE for the Investor Summit, creating an exclusive partnership to connect investors with XPRIZE healthspan competition and longevity research initiatives.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-03-04
Description

Swiss fintech company GenTwo provided the assetization platform enabling Marcuard Heritage to make Maximon's Longevity Fund bankable, investible, and accessible to professional clients.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-18
Description

Biolytica co-organized the Longevity Investors Lunch Davos 2023 alongside Maximon and Longevity Investors Conference. Biolytica's CEO Rob Konrad Maciejewski served as co-host.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-05-25
Description

Deep Knowledge Group sponsored the Longevity Investors Lunch Davos 2022 and provided keynote presentation on longevity industry overview and Swiss Longevity Valley.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

NUS sponsored the Davos 2023 event, with Dr. Brian Kennedy serving as Director of Centre for Healthy Longevity at NUS and presenting on longevity research.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

A dedicated early-stage longevity-focused venture fund backed by Michael Antonov; directly comparable to Maximon's LCIF as a thematic longevity investor, though structured as a pure fund rather than a company builder.

TypeDirect peer
Description

A venture fund investing in longevity and healthspan startups; comparable to Maximon's LCIF mandate, with a similar target of seed/early-stage healthy-aging companies.

TypeDirect peer
Description

A hybrid VC/accelerator focused on longevity ventures founded by Sergey Young; overlaps with Maximon as a longevity-focused investor and ecosystem builder hosting conferences and community events.

TypeEmerging player
Description

Operates longevity/preventive-health clinics and a consumer supplement line; comparable to Maximon's AYUN clinic and AVEA supplements portfolio but as a single integrated operator rather than a multi-venture builder.

TypeEmerging player
Description

Founded by Peter Diamandis/Craig Venter to deliver data-driven preventive longevity diagnostics and care; overlaps with Maximon's AYUN clinic and Data-Driven Health Analytics venture.

TypeDirect peer
Description

Evidence-based longevity supplement company built around NAD+ science with a strong scientific advisory board; directly comparable to Maximon's AVEA supplements portfolio in product, science-led positioning, and channel.

TypeBroad incumbent
Description

US healthcare company builder that launches multiple health ventures per year; analogous business model to Maximon but with much greater scale, broader health verticals, and US-centric operations.

TypeEmerging player
Description

Biomarker-driven personalized health and longevity platform with consumer subscription products; comparable to Maximon's AYUN biomarker-led longevity offerings and Data-Driven Health Analytics venture.

TypeDirect peer
Description

European venture fund investing in longevity science and biotech; comparable thematic focus to Maximon's LCIF but with a biotech-rather-than-D2C/supplements portfolio emphasis.

10Swiss Longevity Science Association
TypeOthers
Description

Swiss industry association promoting longevity research and ecosystem development; thematically related to Maximon's positioning as a Swiss longevity ecosystem leader and organizer of the Longevity Investors Conference.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Maximon

Longevity Company Building and Venture Investmentmaximon.com

Maximon firmographics

Firmographics
Name
Maximon
Legal name
Maximon AG
Website
https://maximon.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Maximon industry classification

Industry
Product category
Longevity Company Building and Venture Investment
NAICS
Corporate, Subsidiary, and Regional Managing Offices (551114), Continuing Care Retirement Communities (623311)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHSADAGAK
Healthy Aging & Longevity Lifestyle Coaching
SECONDARYCRADAGAM
Healthy Aging & Cognitive Support Supplements

Keywords

  • Longevity company building
  • Venture building services
  • Healthy aging solutions
  • Longevity investment fund
  • Biotech venture incubation

Where Maximon is headquartered

Location

Headquarters

HQ city
Zug
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Maximon business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. Company Builder Equity Stakes: Maximon builds and operationalizes longevity companies from scratch, taking equity stakes in portfolio companies. As companies become operational and profitable (e.g., Avea Life reaching profitability), Maximon benefits through equity appreciation and potential exits.
  2. Longevity Co-Investment Fund Management: Maximon manages the Longevity Co-Investment Fund (LCIF) targeting CHF 100 million with minimum tickets of CHF 500,000 for qualified investors. Additional investment vehicle launched January 2024 for qualified investors. Revenue derived from management fees and carried interest.
  3. Actively Managed Certificate (AMC): Partnership with Marcuard Heritage and GenTwo to offer an AMC structure allowing professional investors access to Maximon's longevity portfolio starting at CHF 10,000, democratizing longevity investments.
  4. Longevity Clinic Services: Portfolio company AYUN operates a longevity clinic in Zurich offering subscription-based health services including comprehensive check-ups, biomarker analysis, and personalized longevity programs.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualLongevity Co-Investment Fund (LCIF) for qualified institutional investors
SubscriptionAnnualActively Managed Certificate (AMC) for professional investors
SubscriptionMonthlyAYUN Longevity Clinic subscription services

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Maximon product offering

Product offering

Core offering

Maximon is a longevity company builder that identifies promising business opportunities in the healthy aging and rejuvenation sector and builds companies from scratch, providing funding, operational infrastructure, HR support, and a curated ecosystem. The company also manages the Longevity Co-Investment Fund (LCIF) with a CHF 100 million target volume for institutional investors, and operates portfolio companies spanning supplements, longevity clinics, women's health, and senior living.

Product overview

Maximon is a longevity company builder that identifies business opportunities in the longevity field and builds companies from scratch. The company operates as a platform with multiple portfolio ventures at various stages: operational companies (Evidence-Based Longevity Supplements, Data-Driven Health Analytics, Avea Life), launching ventures (LIV Lounge, Senior Co-Living, AYUN clinic), and stealth projects (Maximon X). Key offerings include AYUN (longevity clinic), Avea Life (supplements), Frieda Health (women's health platform), alongside investment vehicles like the Longevity Co-Investment Fund and the annual Longevity Investors Conference. Maximon provides proven structures, financing, and an ecosystem for entrepreneurs building longevity ventures.

Differentiator

Problem solved

Functional benefit

Brands

  • AVEA: Evidence-based longevity supplements company
  • AYUN
  • Frieda Health
  • Longevity Investors Conference
  • Longevity Co-Investment Fund (LCIF)

Products and services

  • Evidence-Based Longevity Supplements (AVEA) A portfolio venture (AVEA) developing and commercializing evidence-based dietary supplements targeted at extending healthspan and promoting healthy aging. Includes Collagen Activator formula and other longevity supplements for health-conscious consumers and corporate partners like SailGP German Team.
  • AYUN Longevity Clinic A portfolio venture (AYUN) operating a longevity clinic in Zurich offering personalized health assessments, preventive medicine services, biomarker analysis, and personalized longevity programs on a subscription basis. Particularly popular among financial sector professionals seeking health optimization.
  • Frieda Health Digital Platform A portfolio venture (Frieda Health) providing a digital health platform focused on women's health, particularly for women aged 45+ during menopause. Raised EUR 2.5 million in pre-seed funding from Maximon.
  • Longevity Co-Investment Fund (LCIF) A co-investment fund with target volume of CHF 100 million for longevity ventures. Minimum ticket of CHF 500,000 for direct investment, with an actively managed certificate (AMC) option starting at CHF 10,000 for professional investors via the Marcuard Heritage and GenTwo partnership.
  • Data-Driven Health Analytics A portfolio venture (operational status) providing data analytics solutions for health insights and longevity optimization.
  • Senior Co-Living A portfolio venture (launching status) focused on co-living solutions for active and healthy seniors, addressing housing and community needs for the longevity society.
  • LIV Lounge A portfolio venture (launching status) focused on longevity services within the Maximon ecosystem.

Quantifiable outcome

  • Avea Life growing at 300-400% annually and already profitable within 2.5 years of market entry
  • +2 more outcomes

Companies that use Maximon

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Maximon technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Maximon partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor and core.

  • Health2Wealth AssociationminorGTM or Marketing Partner · 2 July 2025AYUN partnered with Health2Wealth Association for a longevity networking event, expanding reach to health and wellness professionals and enthusiasts.
  • SailGP German TeamminorChannel Partner/ Reseller/ Distributor · 17 June 2025AVEA became Official Supplier of the SailGP German Team, demonstrating B2B enterprise adoption of longevity supplements for athletic performance optimization.
  • Eat by AlexminorStrategic or Co-development Partner · 29 May 2025Avea partnered with Eat by Alex to infuse Avea's Collagen Activator formula into a special version of their clean plant protein powder, expanding product distribution.
  • XPRIZEcoreStrategic or Co-development Partner · 13 May 2025Longevity Investors partnered with XPRIZE for the Investor Summit, creating an exclusive partnership to connect investors with XPRIZE healthspan competition and longevity research initiatives.
  • GenTwocoreTechnology or Integration · 4 March 2024Swiss fintech company GenTwo provided the assetization platform enabling Marcuard Heritage to make Maximon's Longevity Fund bankable, investible, and accessible to professional clients.
  • BiolyticacoreStrategic or Co-development Partner · 18 January 2023Biolytica co-organized the Longevity Investors Lunch Davos 2023 alongside Maximon and Longevity Investors Conference. Biolytica's CEO Rob Konrad Maciejewski served as co-host.
  • Deep Knowledge GroupminorStrategic or Co-development Partner · 25 May 2022Deep Knowledge Group sponsored the Longevity Investors Lunch Davos 2022 and provided keynote presentation on longevity industry overview and Swiss Longevity Valley.
  • National University of Singapore (NUS)minorStrategic or Co-development PartnerNUS sponsored the Davos 2023 event, with Dr. Brian Kennedy serving as Director of Centre for Healthy Longevity at NUS and presenting on longevity research.

Scale indicators6 records

Recent moves7 records

Expansion highlights7 records

Maximon competitors and assessment

Company assessment

Direct peers

  • LongeVC: A dedicated early-stage longevity-focused venture fund backed by Michael Antonov; directly comparable to Maximon's LCIF as a thematic longevity investor, though structured as a pure fund rather than a company builder.
  • The Longevity Fund: A venture fund investing in longevity and healthspan startups; comparable to Maximon's LCIF mandate, with a similar target of seed/early-stage healthy-aging companies.
  • Longevity Vision Fund: A hybrid VC/accelerator focused on longevity ventures founded by Sergey Young; overlaps with Maximon as a longevity-focused investor and ecosystem builder hosting conferences and community events.
  • Elysium Health: Evidence-based longevity supplement company built around NAD+ science with a strong scientific advisory board; directly comparable to Maximon's AVEA supplements portfolio in product, science-led positioning, and channel.
  • Apollo Health Ventures: European venture fund investing in longevity science and biotech; comparable thematic focus to Maximon's LCIF but with a biotech-rather-than-D2C/supplements portfolio emphasis.

Emerging players

  • Fountain Life: Operates longevity/preventive-health clinics and a consumer supplement line; comparable to Maximon's AYUN clinic and AVEA supplements portfolio but as a single integrated operator rather than a multi-venture builder.
  • Human Longevity Inc. Founded by Peter Diamandis/Craig Venter to deliver data-driven preventive longevity diagnostics and care; overlaps with Maximon's AYUN clinic and Data-Driven Health Analytics venture.
  • InsideTracker: Biomarker-driven personalized health and longevity platform with consumer subscription products; comparable to Maximon's AYUN biomarker-led longevity offerings and Data-Driven Health Analytics venture.

Broad incumbents

  • Redesign Health: US healthcare company builder that launches multiple health ventures per year; analogous business model to Maximon but with much greater scale, broader health verticals, and US-centric operations.

Others

  • Swiss Longevity Science Association: Swiss industry association promoting longevity research and ecosystem development; thematically related to Maximon's positioning as a Swiss longevity ecosystem leader and organizer of the Longevity Investors Conference.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Maximon social profiles

Digital presence

Maximon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Maximon leadership team

Management profile

Number of profiles

Profiles15 records

Maximon subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Maximon funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Maximon M&A and investment

M&A and investment

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maximon

What does Maximon do?

Maximon is a longevity company builder that identifies promising business opportunities in the healthy aging and rejuvenation sector and builds companies from scratch, providing funding, operational infrastructure, HR support, and a curated ecosystem. The company also manages the Longevity Co-Investment Fund (LCIF) with a CHF 100 million target volume for institutional investors, and operates portfolio companies spanning supplements, longevity clinics, women's health, and senior living.

Is Maximon a public or private company?

Maximon is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Maximon founded?

Maximon was founded in 2021. It employs 11 to 50 people.

Where is Maximon based?

Maximon is headquartered in Zug, Switzerland, in the Europe region.

How does Maximon make money?

Four revenue lines are on record. Company Builder Equity Stakes are the primary driver. The others are longevity Co-Investment Fund Management, actively Managed Certificate (AMC) and longevity Clinic Services.

Who are Maximon's main competitors?

Direct peers on record are LongeVC, The Longevity Fund, Longevity Vision Fund, Elysium Health and Apollo Health Ventures. Emerging players are Fountain Life, Human Longevity Inc. and InsideTracker. Redesign Health is listed as a broad incumbent. Swiss Longevity Science Association is listed as an others.

Does Maximon have an API?

No public API is recorded for Maximon.

What industry is Maximon in?

Maximon's product category is Longevity Company Building and Venture Investment. Its primary akta.pro industry code is HSADAGAK, Healthy Aging & Longevity Lifestyle Coaching, with a secondary code of CRADAGAM, Healthy Aging & Cognitive Support Supplements. Its NAICS code is 551114 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Longevity.TechnologyLongevity capital heads to GstaadThe seventh Longevity Investors Conference will take place in Gstaad, Switzerland from September 14-17, bringing together investors, founders, scientists and clinicians to discuss longevity science and the capital needed to advance it from laboratory to clinical application. The 2026 programme features debates and masterclasses led by prominent figures including Dr. Steve Horvath, Dr. Aubrey de Grey, and Dave Asprey, alongside a Start-Up Innovation Catalyst for early-stage companies. HSBC Private Bank has joined as a strategic partner alongside returning sponsors including Maximon, Tomorrow Biostasis, Maerki Baumann and Niagen Bioscience, the first publicly traded longevity company on NASDAQ to partner with the event.MaximonCHF2.5 million to support the growth of longevity start-up AVEALongevity supplement start-up AVEA Life has closed a 2.5 million CHF seed financing round. The investment was led by Maximon, The Longevity Company Builder, and its Longevity Co-Investment Fund.LifespanAVEA closes 2.5 million funding roundAVEA, a longevity supplement startup, closed a 2.5 million CHF seed round led by Maximon at the World Economic Forum in Davos. The funding will support growth across Switzerland, Germany, Austria, and the UK, and scientific research. AVEA launched its first products in February 2022.startupticker.chFirst companies benefit from Maximon's Longevity Co-Investment FundMaximon launched a CHF 100 million Longevity Co-Investment Fund, with the first closing at CHF 6 million. Two start-ups, Avea and Biolytica, have been established and will receive up to CHF 10 million each. The fund will remain open for 18+ months.